Follow
Ian Williamson
Title
Cited by
Cited by
Year
A high-throughput organoid microinjection platform to study gastrointestinal microbiota and luminal physiology
IA Williamson, JW Arnold, LA Samsa, L Gaynor, M DiSalvo, JL Cocchiaro, ...
Cellular and molecular gastroenterology and hepatology 6 (3), 301-319, 2018
2082018
Self-renewing monolayer of primary colonic or rectal epithelial cells
Y Wang, M DiSalvo, DB Gunasekara, J Dutton, A Proctor, MS Lebhar, ...
Cellular and molecular gastroenterology and hepatology 4 (1), 165-182. e7, 2017
1942017
A high-throughput platform for stem cell niche co-cultures and downstream gene expression analysis
AD Gracz, IA Williamson, KC Roche, MJ Johnston, F Wang, Y Wang, ...
Nature cell biology 17 (3), 340-349, 2015
1552015
Patient-derived micro-organospheres enable clinical precision oncology
S Ding, C Hsu, Z Wang, NR Natesh, R Millen, M Negrete, N Giroux, ...
Cell Stem Cell 29 (6), 905-917. e6, 2022
782022
IL22 inhibits epithelial stem cell expansion in an ileal organoid model
B Zwarycz, AD Gracz, KR Rivera, IA Williamson, LA Samsa, J Starmer, ...
Cellular and molecular gastroenterology and hepatology 7 (1), 1-17, 2019
722019
Glycerate from intestinal fructose metabolism induces islet cell damage and glucose intolerance
Y Wu, CW Wong, EN Chiles, AL Mellinger, H Bae, S Jung, T Peterson, ...
Cell metabolism 34 (7), 1042-1053. e6, 2022
162022
713c Dietary Fat Increases Intestinal Fructose Conversion to Glycerate that Accumlates in Circulation, Driving Glucose Intolerance
IA Williamson, CW Wong, Y Wu, X Su, JF Rawls, X Shen
Gastroenterology 161 (2), e25-e26, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–7